If the hypothesis holds water that IgM+ B cells are involved in the primary step to autoimmunity, and their activation is dependent on TLR7 ligands conveying an aberrant signal to these cells, pharmacological suppression could be beneficial for the plethora of IgM mediated autoimmune diseases discussed. The gene discussed is TLR7; the disease is autoimmune disease.